Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the treatment of obesity. This drug works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://safasyux792954.newbigblog.com/45571581/trelaglutide-exploring-a-new-therapy-for-chronic-diseases